| Identification | |
| Name: | 2-Amino-3,8-dimethylimidazo(4,5-f)quinoxaline |
| Synonyms: | 3H-Imidazo(4,5-f)quinoxaline, 2-amino-3,8-dimethyl-;3,8-Dimethyl-3H-imidazo(4,5-f)quinoxalin-2-amine;8-Methyl-IQX;2-Amino-3,8-dimethyl-3H-imidazo(4,5-f)quinoxaline;3H-Imidazo[4,5-f]quinoxalin-2-amine,3,8- dimethyl-;8-MeIQX;3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,8-dimethyl-;MeIQx;3,8-DIMETHYL-3H-IMIDAZO(4,5-f) QUINOXALIN-2-AMINE;2-AMINO-3,8-DIMETHYL-3H-IMIDAZO(4,5-f) QUINOXALINE; |
| CAS: | 77500-04-0 |
| Molecular Formula: | C11H11N5 |
| Molecular Weight: | 213.27 |
| InChI: | InChI=1/C11H11N5/c1-6-5-13-7-3-4-8-10(9(7)14-6)15-11(12)16(8)2/h3-5H,1-2H3,(H2,12,15) |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 458.4 °C at 760mmHg |
| Boiling Point: | 458.4 °C at 760mmHg |
| Density: | 1.47 g/cm3 |
| Refractive index: | 1.776 |
| Solubility: | In water 398 mg/L at 25 deg C (est) |
| Specification: |
2-Amino-3,8-dimethylimidazo(4,5-f)quinoxaline also can be called 2-Amino-3,8-dimethyl-3H-imidazo(4,5-f)quinoxaline ; 3,8-Dimethyl-3H-imidazo(4,5-f)quinoxalin-2-amine ; 8-MeIQX ; 8-Methyl-IQX ; BRN 4188271 ; CCRIS 2536 . |
| Report: |
IARC Cancer Review: Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 56 (1993),p. 211.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 56 (1993),p. 211.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 40 (1986),p. 283.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 40 (1986),p. 283.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 56 (1993),p. 211.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . |
| Flash Point: | 458.4 °C at 760mmHg |
| Storage Temperature: | Refrigerator |
| Usage: |
2-Amino-3,8-dimethylimidazo(4,5-f)quinoxaline (CAS NO.77500-04-0) has been used for diet meat mutagen heterocyclic amine colorectal adenoma recurrence. |
| Safety Data | |
 |
|
